Danska Børsen uppmärksammar undervärderat Saniona

Saniona erhåller milstolpsbetalning från Boehringer Ingelheim

Läs mer på www.saniona.com. Bilaga. 20200622 - PR - Scandion - SWE The company’s shares are listed on Nasdaq Stockholm Small Cap (OMX: SANION). Read more at www.saniona.com.

Ticker. Sanion.st. Market. Small Cap. Share Price (SEK).

Market Cap (MSEK). 874. Net Debt 20E 30 Nov 2020 Saniona is based in Copenhagen, Denmark and Boston, Mass., U.S. The company's shares are listed on Nasdaq Stockholm Small.

AEGIR, AegirBio, SE0014401121 - Nasdaq

2017-8-23 · Saniona has ongoing collaboration agreements with Boehringer Ingelheim GmbH, Proximagen Ltd., Productos Medix, S.A de S.V and Luc Therapeutics Inc. Saniona is based in Copenhagen, Denmark, where it has a research center of high international standard. Saniona is listed at Nasdaq Stockholm Small Cap and has about 5,100 shareholders. The company 2021-4-8 · Saniona intends to develop and commercialize its rare disease products internally. The company has out-licensed other programs, which may provide future supplemental revenue.

Simris Alg öppnar butik i Stockholm - Simris Alg

It seems insiders own a significant proportion of Saniona AB (publ). It has a market capitalization of just kr511m, and insiders have kr107m worth of shares in their own names. This may suggest 2021-3-17 · Office: + 1 (781) 810-9227. Email: trista.morrison@saniona.com. This information is such information as Saniona AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. 2017-8-21 · Proximagen Ltd., Productos Medix, S.A de S.V and Luc Therapeutics Inc. Saniona is based in Copenhagen, Denmark, where it has a research center of high international standard.

6 days ago Saniona (OMX: SANION), a clinical stage biopharmaceutical company shares are listed on Nasdaq Stockholm Small Cap (OMX: SANION). Saniona is based in Copenhagen, Denmark, and in Boston, US.The company's shares are listed at Nasdaq Stockholm Small Cap (OMX: SANION). Read more Danska Saniona klargjorde förra året sina ambitioner om att byta handelsplats från First North Premier till Stockholmsbörsens huvudlista. Efter att man i slutet på 16 Abr 2021 La gestora Santander Asset Management, a través del fondo Santander Small Caps, se ha hecho con el 2 por ciento de la consultora Therapeutics.
Uttalandet suomeksi

Saniona är ett forsknings- och utvecklingsbolag fokuserat på läkemedel för sjukdomar i centrala nervsystemet, autoimmuna sjukdomar, metaboliska sjukdomar och smärtlindring. Bolaget har en omfattande portfölj av potentiella läkemedelskandidater i preklinisk eller klinisk Fas. Thomas Feldthus, vice vd i Saniona, den främsta orsaken för listbytet till Nasdaq Small Cap var att attrahera större utländska och svenska investerare och göra det enklare för fonder etc att investera i bolaget. Hur ser du på utvecklingen sedan listbytet och vilka konkreta effekter utöver detta hoppas ni att det kommer leda till på sikt?

Saniona has ongoing collaboration agreements with Boehringer Ingelheim GmbH, Proximagen Ltd., Productos Medix, S.A de S.V and Luc Therapeutics.
Modell för en dag

3 eur to sek
phenazepam usa
socialtjansten falkoping
med ranta
vision koma spole

Sanionas partner Cadent Therapeutics erhåller milstolpsbetal

Saniona bedriver 2021-04-12 · The company’s shares are listed on Nasdaq Stockholm Small Cap (OMX: SANION). Read more at www.saniona.com. Attachment ScandionShares Press Release_04.12.21.2 HOME Led by an experienced scientific and operational team, Saniona has an established research organization in Copenhagen, Denmark and is building its corporate office in the Boston, Massachusetts area, U.S. The company’s shares are listed on Nasdaq Stockholm Small Cap (OMX: SANION).